Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Terminal heart failure].

Francesc Formiga1, Nicolás Manito, Ramón Pujol

  • 1UFISS Geriatría, Servicio de Medicina Interna, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España. fformiga@csub.scs.es

Medicina Clinica
|March 6, 2007
PubMed
Summary

Heart failure (HF) is a progressive cardiovascular disease with high mortality. Identifying and managing end-stage HF patients is crucial for better care, as current treatments only slow progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of fall recurrence among persistent, quasi-persistent, and transient fallers: a 3-year analysis from the SCOPE study.

European geriatric medicine·2026
Same author

Real-world dosing patterns and outcomes of edoxaban in patients with non-valvular atrial fibrillation and type 2 diabetes mellitus: A gender perspective study.

Medicina clinica·2026
Same author

Impact of age on the prognostic benefit of follow-up in UMIPIC units: analysis of the RICA registry.

Internal and emergency medicine·2026
Same author

Serum chloride and the response to hydrochlorothiazide in patients with acute heart failure: a post-hoc analysis from the CLOROTIC trial.

Revista espanola de cardiologia (English ed.)·2026
Same author

Acute declines in kidney function with thiazide plus loop diuretics vs loop diuretics alone in acute decompensated heart failure.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Statin use does not impair muscle health in older adults: findings from the SCOPE study.

Aging clinical and experimental research·2026

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Context:

  • Heart failure (HF) is a growing global health concern with increasing prevalence, incidence, and mortality.
  • Current therapeutic strategies for HF offer symptomatic relief and can slow disease progression but do not provide a cure.
  • High mortality rates associated with HF persist, even at the disease's initial presentation.

Purpose:

  • To highlight the challenges in predicting the course of heart failure and identifying patients in the terminal stage of the disease.
  • To underscore the gap in perception regarding HF as a progressive, terminal illness among patients, families, and healthcare professionals.
  • To advocate for improved identification and management strategies for end-stage heart failure patients.

Summary:

  • Heart failure (HF) is characterized by relentless progression and significant mortality, with approximately 40% of deaths attributed to disease advancement.
  • The unpredictable trajectory of HF makes timely identification of the terminal stage difficult, leading to suboptimal care decisions.
  • A common misconception among patients, families, and healthcare providers is that HF is not a terminal condition, resulting in potentially futile treatments near the end of life.

Impact:

  • Improved recognition of HF as a progressive, terminal disease is essential for healthcare providers.
  • Enhanced identification of end-stage HF patients will facilitate more appropriate and compassionate care planning.
  • A shift in focus towards palliative and supportive care for terminal HF patients can improve quality of life and reduce the burden of futile interventions.

Related Experiment Videos